Concordance treatment continuum: A proposed clinical outcome to boost concordance with compression therapy

Chloe Jansz1, William McGuiness2, Sonja Cleary3

  • 1Healthcare United - Director of Nursing Services and Nurse Practitioner, 2/44 Eleanor St, Footscray, VIC, 3011, Australia.

PubMed

Insights

Patient adherence to compression therapy for venous leg ulcers is low, increasing recurrence risk. Identifying factors for comfort, motivation, and healthcare access is key to improving long-term treatment concordance.

Area of Science:

  • Vascular Medicine
  • Dermatology
  • Public Health

Background:

  • Chronic venous insufficiency (CVI) affects 1-3% of the population.
  • Venous leg ulcers (VLUs) develop in 60-80% of CVI patients.
  • Low patient adherence (39.9%) to compression therapy (CT) leads to VLU recurrence and increased healthcare costs.

Purpose of the Study:

  • To identify factors influencing long-term patient concordance with compression therapy for venous leg ulcers.
  • To explore clinician and patient perspectives on barriers and facilitators to CT adherence.
  • To inform the development of a clinical guideline for improved VLU management.

Main Methods:

  • Two Delphi studies were conducted to gather expert consensus.
  • A total of 105 factors influencing CT concordance were identified.
  • Analysis focused on consensus areas including comfort, motivation, healthcare access, and clinician attributes.

Main Results:

  • Clinicians and patients identified distinct factors affecting long-term CT concordance.
  • Consensus was reached on factors related to patient comfort, motivation, healthcare accessibility, and clinician characteristics.
  • Understanding these factors is crucial for addressing the challenge of VLU recurrence.

Conclusions:

  • Improving long-term concordance with compression therapy is essential for managing venous leg ulcers.
  • A comprehensive approach addressing patient and clinician factors is needed.
  • Further research should integrate identified factors into clinical guidelines to enhance VLU treatment outcomes and reduce recurrence.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
94
Nursing Clinical Information System01:27

Nursing Clinical Information System

Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
707